Pfizer Inc
NYSE: PFE
$24.80
-$1.22 (-4.7%)
Closing Price on November 15, 2024
PFE Articles
August 16, 2013: U.S. equity markets opened lower this morning following big down day on Thursday. In the U.S., the Census Bureau’s report on July housing starts put up a positive number, while...
Published:
Last Updated:
Brian Solis, via Wikimedia CommonsOn the day that Facebook Inc. (NASDAQ: FB) came public last year, more than 580 million shares of the company’s stock changed hands. No other trading day since...
Published:
Last Updated:
July 30, 2013: U.S. equity markets opened higher this morning as traders and investors wait for tomorrow’s announcement from the FOMC. There was little economic data published today. In the U.S.,...
Published:
Last Updated:
Wikimedia CommonsWhenever you see huge restructurings and reclassifications for a major corporation, the first thing that should come to mind is whether a company is about to break itself up...
Published:
ThinkstockShort sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in June and rising interest rates are obviously making...
Published:
ThinkstockStephen A. Cohen, the founder and owner of SAC Capital Advisors LLC, has been charged by the U.S. Securities and Exchange Commission (SEC) with “failing reasonably to supervise two of his...
Published:
Last Updated:
July 12, 2013: U.S. equity markets opened slightly higher this morning as European industrial production was below expectations and U.S. PPI was a bit higher than expected. The other major U.S. data...
Published:
Last Updated:
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Friday, July 12, 2013. They include F5 Networks, Pfizer, Sprint, Kroger and Target.
Published:
Last Updated:
ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a stalking horse bid, that’s what many observers...
Published:
Last Updated:
Wikimedia CommonsIn a sign that Pfizer Inc. (NYSE: PFE) has more cash on hand than the sense to use it wisely to create new drugs, its board approved a $10 billion share buyback. Pfizer has...
Published:
Jon OggShort sellers have really made some big changes in their bets against the key high-yield dividend stocks that had been the darling of Wall Street. Many of these stocks are members of the Dow...
Published:
ThinkstockEven the best firms on Wall Street sometimes lose their analysts, and when that happens they are forced to suspend their coverage on stocks until they can replace the talent. Oppenheimer...
Published:
Last Updated:
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their...
Published:
Last Updated:
Jon OggThe bull market appears to still be alive and well for equities, but the risk of rising interest rates is plaguing bonds and investments tied to big dividends. What equity investors also need...
Published:
Last Updated:
U.S. equity markets opened barely higher this morning following a report that mortgage loan applications had fallen by 9.8% from the previous week, on top of a 7% decline for the prior period. In...
Published:
Last Updated: